Luckett, Tim, Newton-John, Toby, Phillips, Jane, Holliday, Simon, Giannitrapani, Karleen, Powell-Davies, Gawaine, Lovell, Melanie, Liauw, Winston, Rowett, Debra, Pearson, Sallie-Anne, Raymond, Bronwyn, Heneka, Nicole, Lorenz, Karl. British Medical Journal (BMJ); 2020. Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners.

Liu, Zheng, Martin, Jennifer H., Hatzimihalis, Athena, Campbell, Ian, Crowley, Simone, Beale, Phillip J., Karapetis, Christos S., Price, Timothy, Burge, Mathew E., Michael, Michael, Liauw, Winston, Mclachlan, Sue-Anne, Link, Emma, Matera, Anetta, Thompson, Michael, Jefford, Michael, Hicks, Rod J., Cullinane, Carleen. Springer; 2021. Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites.

Waller, Amy, Girgis, Afaf, Johnson, Claire, Lecathelinais, Christophe, Sibbritt, David, Forstner, Dion, Liauw, Winston, Currow, David C.. Elsevier; 2012. Improving outcomes for people with progressive cancer: interrupted time series trial of a needs assessment intervention.

Daniels, Benjamin, Luckett, Tim, Holliday, Simon, Liauw, Winston, Lovell, Melanie, Phillips, Jane, Rowett, Debra, John, Toby Newton, Tervonen, Hanna, Pearson, Sallie-Anne. Wiley-Blackwell; 2021. Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study.